NASDAQ: TVTX · Biotechnology
Over the past week, Travere Therapeutics (TVTX) pulled in 12 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 64% bullish but is deeply split: Reddit runs 100% bullish while News sits at just 43%. Wall Street is more constructive, with 14 of 15 analysts rating TVTX a buy.
There is little buzz around TVTX this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 93% buy share sits next to a crowd that ranges from News at 43% to Reddit at 100%. No other tracker puts the two side by side.
Across 15 analysts the consensus is a Strong Buy: 14 buy calls against 0 sell, with an average 12-month price target of $75.21.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 29 points above the crowd average of 64%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while News sits at 43%, a 57-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Travere Therapeutics (TVTX) buzz held subdued around 23.1 while the price drifted down 9.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.5M shares. Updated Sep 26, 2026. Over the last 7 trading days, TVTX lost 8.2%. Buzz activity in the recent week averaged 30.0 and was relatively stable, swinging between 23.1 and 34.4. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 11 of the 13 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for TVTX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live TVTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 27, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (14 / 1 / 0) |
| Crowd bullish (7d) | 64% |
| Avg price target | $75.21 |
| Most bullish source | Reddit, 100% |
| Most bearish source | News, 43% |
| Sentiment spread | 57 pts |
| Mentions (7d) | 12 |
| Market cap | $5.71B |
| P/E · Forward P/E | n/a · 39.8 |
| EPS · Beta | -$0.74 · 1.1 |
| Revenue (TTM) | $591.3M · -7% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Travere Therapeutics (TVTX) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 64% bullish across 3 active sources. Those sources contribute 12 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Travere Therapeutics (TVTX) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Travere Therapeutics (TVTX), averaging 64% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and News at 43%, a 57-point spread. On the professional side, 14 of 15 analysts rate TVTX a buy.
Of the 15 analysts covering Travere Therapeutics (TVTX), 14 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $75.21. That puts the street ahead of the crowd, which averages 64% bullish.
Travere Therapeutics (TVTX)'s cross-source average is bullish at 64% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. Reddit reads 100% bullish, X reads 50% bullish and news coverage is the most negative at 43% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Travere Therapeutics (TVTX) at 64% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is news at 43% bullish. 3-day activity momentum is rising across News. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 7 mentions (58% of total volume). X contributes 4 mentions and Reddit contributes 1 mention. The cross-source average is bullish at 64% bullish, while news is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. TVTX's buy signal at 93/100 conviction reflects a bullish cross-source average at 64% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The TVTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key